Uncertainties and Controversies in the Management of Ischemic Stroke and Transient Ischemic Attack Patients With

Scott E Kasner1, Simona Lattanzi2, Ana Catarina Fonseca3

  • 1Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia (S.E.K.).

Stroke
|October 27, 2021
PubMed

Insights

Patent foramen ovale closure benefits stroke patients, but questions remain regarding optimal patient selection, diagnosis, and treatment. This review clarifies current data and suggests future research directions for patent foramen ovale (PFO) stroke management.

Area of Science:

  • Cardiology
  • Neurology
  • Medical Device Technology

Background:

  • Patent foramen ovale (PFO) closure shows benefit over medical therapy for cryptogenic stroke.
  • Significant uncertainties persist regarding patient selection, pathophysiology, diagnosis, and treatment strategies for PFO-related strokes.

Purpose of the Study:

  • To review and synthesize current data on PFO closure for stroke.
  • To address controversies and uncertainties in PFO stroke management.
  • To provide clinical clarity and future research directions.

Main Methods:

  • Systematic review of randomized clinical trials.
  • Analysis of data on patient selection, pathophysiology, diagnosis, and treatment.
  • Synthesis of existing literature.

Main Results:

  • Evidence supports PFO closure for specific stroke patient groups.
  • Key areas of controversy include optimal closure device selection and long-term outcomes.
  • Diagnostic criteria and patient stratification require further refinement.

Conclusions:

  • PFO closure is a valuable therapeutic option for select stroke patients.
  • Further research is needed to optimize patient selection and treatment protocols.
  • Standardized diagnostic and management guidelines are essential for PFO-related stroke.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
44
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
38
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
48
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
51
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
69
Regulation of Stroke Volume01:27

Regulation of Stroke Volume

The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
4.2K